These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 20861040)

  • 1. Regulating interface science healthcare products: myths and uncertainties.
    Bravery CA
    J R Soc Interface; 2010 Dec; 7 Suppl 6(Suppl 6):S789-95. PubMed ID: 20861040
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulatory enablers and regulatory challenges for the development of tissue-engineered products in the EU.
    Brévignon-Dodin L
    Biomed Mater Eng; 2010; 20(3):121-6. PubMed ID: 20930319
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A critical assessment of the directive on tissue engineering of the European union.
    Trommelmans L; Selling J; Dierickx K
    Tissue Eng; 2007 Apr; 13(4):667-72. PubMed ID: 17253926
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulatory 'desirables' for new health technologies.
    Farrell AM; Devaney S; Hervey TK; Murphy T
    Med Law Rev; 2013; 21(1):1-10. PubMed ID: 23420772
    [No Abstract]   [Full Text] [Related]  

  • 5. Regulatory or regulating publics? The European Union's regulation of emerging health technologies and citizen participation.
    Flear ML; Pickersgill MD
    Med Law Rev; 2013; 21(1):39-70. PubMed ID: 23222171
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulatory approaches to worker protection in nanotechnology industry in the USA and European union.
    Murashov V; Schulte P; Geraci C; Howard J
    Ind Health; 2011; 49(3):280-96. PubMed ID: 21372443
    [TBL] [Abstract][Full Text] [Related]  

  • 7. What can be learnt from the Japanese regulatory approach to tissue engineered products?
    Brévignon-Dodin L; Livesey F
    Regen Med; 2007 Nov; 2(6):967-71. PubMed ID: 18034634
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Challenges with advanced therapy medicinal products and how to meet them.
    ; ; Schneider CK; Salmikangas P; Jilma B; Flamion B; Todorova LR; Paphitou A; Haunerova I; Maimets T; Trouvin JH; Flory E; Tsiftsoglou A; Sarkadi B; Gudmundsson K; O'Donovan M; Migliaccio G; Ancāns J; Maciulaitis R; Robert JL; Samuel A; Ovelgönne JH; Hystad M; Fal AM; Lima BS; Moraru AS; Turcáni P; Zorec R; Ruiz S; Akerblom L; Narayanan G; Kent A; Bignami F; Dickson JG; Niederwieser D; Figuerola-Santos MA; Reischl IG; Beuneu C; Georgiev R; Vassiliou M; Pychova A; Clausen M; Methuen T; Lucas S; Schüssler-Lenz M; Kokkas V; Buzás Z; MacAleenan N; Galli MC; Linē A; Gulbinovic J; Berchem G; Fraczek M; Menezes-Ferreira M; Vilceanu N; Hrubisko M; Marinko P; Timón M; Cheng W; Crosbie GA; Meade N; di Paola ML; VandenDriessche T; Ljungman P; D'Apote L; Oliver-Diaz O; Büttel I; Celis P
    Nat Rev Drug Discov; 2010 Mar; 9(3):195-201. PubMed ID: 20190786
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The use of nanotechnology in medicinal products in the light of European Union law].
    Jurewicz M
    Pol Merkur Lekarski; 2014 Dec; 37(222):369-72. PubMed ID: 25715580
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Demand for command: responding to technological risks and scientific uncertainties.
    Stokes E
    Med Law Rev; 2013; 21(1):11-38. PubMed ID: 23329016
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Too small for concern? Public health and nanotechnology.
    Bowman DM; Fitzharris M
    Aust N Z J Public Health; 2007 Aug; 31(4):382-4. PubMed ID: 17725022
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Legal regulation in the field of tissue engineering].
    Farkas B; Bárdos T; Bellyei A; Illés T
    Orv Hetil; 2008 Jun; 149(22):1023-8. PubMed ID: 18508736
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exploring Solutions to Foster ATMP Development and Access to Patients in Europe.
    Salvatore V
    Eur J Health Law; 2020 May; 27(3):259-273. PubMed ID: 33652396
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Purity and the dangers of regenerative medicine: regulatory innovation of human tissue-engineered technology.
    Faulkner A; Kent J; Geesink I; FitzPatrick D
    Soc Sci Med; 2006 Nov; 63(9):2277-88. PubMed ID: 16905231
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of tissue-engineered products in the European Union: where are we heading?
    Brévignon-Dodin L; Livesey F
    Regen Med; 2006 Sep; 1(5):709-14. PubMed ID: 17465739
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Encountering Challenges with the EU Regulation on Advance Therapy Medical Products.
    Mansnérus J
    Eur J Health Law; 2015 Dec; 22(5):426-61. PubMed ID: 26665690
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Current issues in the regulation of human tissue-engineering products in the European Union.
    Heinonen M; Oila O; Nordström K
    Tissue Eng; 2005; 11(11-12):1905-11. PubMed ID: 16411837
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Insights into possibilities for grouping and read-across for nanomaterials in EU chemicals legislation.
    Mech A; Rasmussen K; Jantunen P; Aicher L; Alessandrelli M; Bernauer U; Bleeker EAJ; Bouillard J; Di Prospero Fanghella P; Draisci R; Dusinska M; Encheva G; Flament G; Haase A; Handzhiyski Y; Herzberg F; Huwyler J; Jacobsen NR; Jeliazkov V; Jeliazkova N; Nymark P; Grafström R; Oomen AG; Polci ML; Riebeling C; Sandström J; Shivachev B; Stateva S; Tanasescu S; Tsekovska R; Wallin H; Wilks MF; Zellmer S; Apostolova MD
    Nanotoxicology; 2019 Feb; 13(1):119-141. PubMed ID: 30182766
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulatory barriers to tissue-engineered products.
    Schutte E
    Med Device Technol; 2002 Mar; 13(2):27-9. PubMed ID: 11984990
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Considerations on the EU definition of a nanomaterial: science to support policy making.
    Bleeker EA; de Jong WH; Geertsma RE; Groenewold M; Heugens EH; Koers-Jacquemijns M; van de Meent D; Popma JR; Rietveld AG; Wijnhoven SW; Cassee FR; Oomen AG
    Regul Toxicol Pharmacol; 2013 Feb; 65(1):119-25. PubMed ID: 23200793
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.